指南与共识产科

妊娠剧吐研究核心结局指标集:国际共识研究

A core outcome set for hyperemesis gravidarum research: an international consensus study.
指南 / 共识 · BJOG · 2020-03-10

本研究旨在为妊娠剧吐(HG)治疗试验制定核心结局指标集。

要点

  • 利益相关者包括研究者、患者及家属、产科及其他健康专业人员
  • 该指标集旨在标准化HG试验的结局报告,以产生高质量证据

核心结论

  • 该核心结局指标集将有助于标准化妊娠剧吐试验的结局报告。

研究设计与样本

  • 采用改良德尔菲调查结合共识发展会议和咨询轮的国际共识研究。
  • 通过系统综述、半结构化患者访谈、封闭小组会议和指导委员会输入识别潜在核心结局。
  • 改良德尔菲过程由125名利益相关者完成,共识发展会议20人,咨询轮96人。

主要发现

  • 共识结局包括恶心、呕吐、无法耐受口服液体或食物、脱水、体重差异、电解质失衡、静脉液体治疗、妊娠剧吐用药、住院治疗、治疗依从性、患者满意度、日常功能、母亲身体或心理或情绪健康、治疗短期和长期不良反应、母亲死亡、妊娠并发症、考虑或实际终止意愿妊娠、早产、小于胎龄儿、先天畸形、新生儿发病率和后代死亡。

关键数值与推荐

  • 利益相关者包括研究者、有妊娠剧吐经历的女性及其家属、产科健康专业人员和其他健康专业人员。

临床怎么用

  • 临床医生在妊娠剧吐治疗试验中应采用该核心结局指标集,以促进证据标准化和比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop a core outcome set for trials on the treatment of hyperemesis gravidarum (HG). DESIGN: Identification of outcomes is followed by a modified Delphi survey combined with a consensus development meeting and a consultation round. SETTING: An international web-based survey combined with a consensus development meeting. POPULATION: Stakeholders including researchers; women with lived experience of HG and their families; obstetric health professionals; and other health professionals. METHODS: We used systematic review, semi-structured patient interviews, closed group sessions and Steering Committee input to identify potential core outcomes. We conducted two web-based survey rounds, followed by a face-to-face consensus development meeting and a web-based consultation round. MAIN OUTCOME MEASURES: A core outcome set for research on HG. RESULTS: Fifty-six potential outcomes were identified. The modified Delphi process was completed by 125 stakeholders, the consensus development meeting by 20 stakeholders and the consultation round by 96 stakeholders. Consensus was reached in ten domains on 24 outcomes: nausea; vomiting; inability to tolerate oral fluids or food; dehydration; weight difference; electrolyte imbalance; intravenous fluid treatment; use of medication for hyperemesis gravidarum; hospital treatment; treatment compliance; patient satisfaction; daily functioning; maternal physical or mental or emotional wellbeing; short- and long-term adverse effects of treatment; maternal death; pregnancy complications; considering or actually terminating a wanted pregnancy; preterm birth; small for gestational age; congenital anomalies; neonatal morbidity and offspring death). CONCLUSIONS: This core outcome set will help standardise outcome reporting in HG trials. TWEETABLE ABSTRACT: A core outcome set for treatment of hyperemesis gravidarum in order to create high-quality evidence.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Jansen L, Koot MH, Van't Hooft J, et al. A core outcome set for hyperemesis gravidarum research: an international consensus study. BJOG. 2020. PMID: 32056342. doi:10.1111/1471-0528.16172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。